{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:03Z","timestamp":1787440923810,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"National Institutes of Health Center for Scientific Review","doi-asserted-by":"publisher","award":["UG3-DA062506"],"award-info":[{"award-number":["UG3-DA062506"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119535","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T22:54:12Z","timestamp":1780008852000},"page":"119535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oxytocin attenuates respiratory depression and reduces mortality from fentanyl and the combination of xylazine-fentanyl in rats"],"prefix":"10.1016","volume":"200","author":[{"given":"Joan B.","family":"Escobar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Dergacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-5055","authenticated-orcid":false,"given":"Matthew W.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Bethea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod Y.","family":"Polotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7107-1832","authenticated-orcid":false,"given":"David","family":"Mendelowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2026.119535_bib1","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.clinthera.2013.10.001","article-title":"Pain as the fifth vital sign: exposing the vital need for pain education","volume":"35","author":"Morone","year":"2013","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119535_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.biopha.2026.119535_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/08958378.2017.1282065","article-title":"Effects of inhaled aerosolized carfentanil on real-time physiological responses in mice: a preliminary evaluation of naloxone","volume":"29","author":"Wong","year":"2017","journal-title":"Inhal. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119535_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharm. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2026.119535_bib5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00213-022-06125-5","article-title":"Treatment of opioid overdose: current approaches and recent advances","volume":"239","author":"Britch","year":"2022","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.biopha.2026.119535_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis","volume":"371","author":"Torralva","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119535_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: a review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.biopha.2026.119535_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2165\/11203740-000000000-00000","article-title":"Spotlight on buprenorphine\/naloxone in the treatment of opioid dependence","volume":"23","author":"Orman","year":"2009","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.biopha.2026.119535_bib9","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/bcp.14271","article-title":"Dose-dependent naloxone-induced morphine withdrawal symptoms in opioid-dependent males-a double-blinded, randomized study","volume":"86","author":"Weisshaar","year":"2020","journal-title":"Br. J. Clin. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2026.119535_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0196-0644(83)80343-6","article-title":"Naloxone","volume":"12","author":"Handal","year":"1983","journal-title":"Ann. Emerg. Med"},{"key":"10.1016\/j.biopha.2026.119535_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.biopha.2026.119535_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1280289","article-title":"\"Tranq-dope\" overdose and mortality: lethality induced by fentanyl and xylazine","volume":"14","author":"Smith","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119535_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.sleep.2020.05.034","article-title":"Intranasal oxytocin increases respiratory rate and reduces obstructive event duration and oxygen desaturation in obstructive sleep apnea patients: a randomized double blinded placebo controlled study","volume":"74","author":"Jain","year":"2020","journal-title":"Sleep. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119535_bib14","doi-asserted-by":"crossref","first-page":"L825","DOI":"10.1152\/ajplung.00206.2017","article-title":"Benefits of oxytocin administration in obstructive sleep apnea","volume":"313","author":"Jain","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119535_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000496194","article-title":"The effects of oxytocin on withdrawal, craving and stress response in heroin-dependent patients: a randomized, double-blind clinical trial","volume":"25","author":"Moeini","year":"2019","journal-title":"Eur. Addict. Res."},{"issue":"14","key":"10.1016\/j.biopha.2026.119535_bib16","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/bph.13757","article-title":"Oxytocin and opioid addiction revisited: old drug, new applications","volume":"175","author":"Zanos","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119535_bib17","doi-asserted-by":"crossref","first-page":"L357","DOI":"10.1152\/ajplung.00025.2025","article-title":"Functional modulation of retrotrapezoid neurons drives fentanyl-induced respiratory depression","volume":"329","author":"Moreira","year":"2025","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119535_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001476","article-title":"Heroin- and fentanyl-induced respiratory depression in a rat plethysmography model: potency, tolerance, and sex differences","volume":"385","author":"Marchette","year":"2023","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119535_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resp.2010.08.001","article-title":"Modulation of cardiorespiratory function mediated by the paraventricular nucleus","volume":"174","author":"Kc","year":"2010","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119535_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1152\/japplphysiol.00839.2001","article-title":"Paraventricular oxytocin neurons are involved in neural modulation of breathing","volume":"92","author":"Mack","year":"2002","journal-title":"J. Appl. Physiol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119535_bib21","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1113\/JP287845","article-title":"Oxytocinergic signalling in the respiratory parafacial region increases the activity of chemosensitive neurons and respiratory output","volume":"603","author":"Araujo","year":"2025","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119535_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/jpet.121.000535","article-title":"Oxytocin receptor activation rescues opioid-induced respiratory depression by systemic fentanyl in the rat","volume":"378","author":"Brackley","year":"2021","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2026.119535_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad009","article-title":"Oxytocin mediated excitation of hypoglossal motoneurons: implications for treating obstructive sleep apnea","volume":"46","author":"Dergacheva","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.biopha.2026.119535_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2016.12.021","article-title":"The analgesic effects of oxytocin in the peripheral and central nervous system","volume":"103","author":"Xin","year":"2017","journal-title":"Neurochem. Int"},{"issue":"5","key":"10.1016\/j.biopha.2026.119535_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/AJP.0b013e31829f57df","article-title":"Oxytocin and pain: a systematic review and synthesis of findings","volume":"30","author":"Rash","year":"2014","journal-title":"Clin. J. Pain."},{"key":"10.1016\/j.biopha.2026.119535_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neubiorev.2015.04.013","article-title":"Oxytocin and the modulation of pain experience: Implications for chronic pain management","volume":"55","author":"Tracy","year":"2015","journal-title":"Neurosci. Biobehav Rev."},{"issue":"8","key":"10.1016\/j.biopha.2026.119535_bib27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00007632-199404150-00001","article-title":"Intrathecal administration of oxytocin induces analgesia in low back pain involving the endogenous opiate peptide system","volume":"19","author":"Yang","year":"1994","journal-title":"Spine (Philos. Pa 1976)"},{"issue":"5","key":"10.1016\/j.biopha.2026.119535_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/gut.39.5.741","article-title":"Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome","volume":"39","author":"Louvel","year":"1996","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.biopha.2026.119535_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.npep.2012.12.003","article-title":"The interaction between the oxytocin and pain modulation in headache patients","volume":"47","author":"Wang","year":"2013","journal-title":"Neuropeptides"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:47:14Z","timestamp":1787438834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"alternative-id":["S0753332226005718"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119535","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxytocin attenuates respiratory depression and reduces mortality from fentanyl and the combination of xylazine-fentanyl in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119535"}}